Neuroradiology: Page 47

GE files applications for F-18 flutemetamol
By AuntMinnieEurope.com staff writers
The U.S. Food and Drug Administration and the European Medicines Agency have accepted applications from GE Healthcare for review of its investigational F-18 flutemetamol PET amyloid imaging agent.
January 7, 2013
High altitude sickness can lead to long-term brain damage
By Philip Ward
German researchers have used MRI to get a closer look at the potentially devastating neurological impact of high altitude sickness. In research presented at last week's RSNA congress, they showed that mountain climbers can have traces of bleeding in the brain years after the initial incident.
December 2, 2012
2012 12 03 09 25 25 383 Rock Climbing 70
MRI shows brain lesions in women with migraines
By Wayne Forrest
MRI investigations indicate that women who suffer from migraine headaches have more brain lesions than men, but neither gender experiences any cognitive decline from the affliction, according to a Dutch study published in the 14 November issue of the Journal of the American Medical Association.
November 19, 2012
2012 11 19 12 37 11 364 Woman With Migraine 70
Bayer partners with Russia's Medsintez
By AuntMinnieEurope.com staff writers
Bayer Healthcare and Russian drug manufacturer Medsintez have teamed up to manufacture and market diagnostic imaging products and pharmaceuticals to treat infections and neural disorders, while also collaborating in joint research, Bayer said.
November 11, 2012
BioClinica collaborates with TauRx Therapeutics
By AuntMinnieEurope.com staff writers
Clinical trial management firm BioClinica has announced that TauRx Therapeutics of Singapore has signed agreements to use Trident IWR/IVR and imaging core lab solutions to support its upcoming phase III clinical trials.
November 5, 2012
SABRE receives grant for MRI research
By AuntMinnieEurope.com staff writers
The Signal Amplification by Reversible Exchange (SABRE) has been awarded 3.6 million euros ($4.7 million U.S.) from the Wellcome Trust to develop an MRI technique to view molecular activities behind diseases, such as Alzheimer's Disease.
October 23, 2012
EU's CHMP offers positive opinion on Amyvid
By AuntMinnieEurope.com staff writers
Europe's Committee for Medicinal Products for Human Use (CHMP) has recommended approval of Amyvid (florebetapir F-18) for injection as a PET radiotracer to detect beta-amyloid neuritic plaque in patients with cognitive impairment, according to Eli Lilly and its subsidiary Avid Radiopharmaceuticals.
October 18, 2012
Use CT as frontline tool in acute stroke, experts urge
By Philip Ward
Acute stroke patients should be evaluated by noncontrast CT followed by perfusion CT, while MRI should be reserved for more chronic cases of brain ischemia or control examinations in stroke patients. That's the recommendation of an experienced group of specialists from the Czech Republic.
October 10, 2012
2012 10 10 12 32 59 319 2012 10 11 Ct Stroke Thumb
Firms launch neuro intervention device in Europe
By AuntMinnieEurope.com staff writers
MRI Interventions and image-guided therapy firm Brainlab have launched a European commercialization effort for ClearPoint, MRI Interventions' neurointervention system, the two firms said.
September 18, 2012
GE promotes phase III flutemetamol results
By AuntMinnieEurope.com staff writers
GE Healthcare said pooled results from phase III brain autopsy and biopsy studies using its F-18 flutemetamol PET imaging agent demonstrated a strong concordance between the flutemetamol images and beta amyloid brain pathology associated with Alzheimer's disease.
September 10, 2012
Study queries effects of 7T MRI on the brain
By AuntMinnieEurope.com staff writers
Standard head movements made while exposed to electromagnetic fields produced by a 7-tesla MRI scanner seem to temporarily lower concentration and visuospatial awareness, according to a study published online on Monday in Occupational and Environmental Medicine.
August 29, 2012
Boston Scientific nets CE Mark
By AuntMinnieEurope.com staff writers
Interventional technology developer Boston Scientific has received the CE Mark for use of its Precision Plus spinal cord stimulator system in patients who are being treated with the system and need head MRI exams.
August 28, 2012
Previous Page
Page 47 of 59
Next Page